Treatment of insomnia by concomitant therapy with Zopiclone and Aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer's disease and Parkinson's disease

Psychiatry and Clinical Neurosciences

Volumn 52, Issue 2, 1998, Pages 198-200

  Katsunuma, H ^a,c   Shimizu, T ^a   Ogawa, K ^a   Kubo, H ^a   Ishida, H ^a   Yoshihama, A ^b  

^a Tachikawa Medical Center   (Japan)

^b Kashiwazaki Central Hospital   (Japan)

^c NONE   (Japan)

Author keywords

Aged; Alzheimer's disease; Aniracetam; Cerebral infarction; Cerebroatrophy; Parkinson's disease; Zopiclone

Indexed keywords

ANIRACETAM; IODINE 123; ZOPICLONE;

AGED; ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN INFARCTION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; INSOMNIA; PARKINSON DISEASE; SLEEP TIME;

EID: 0031832391     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.1998.tb01028.x     Document Type: Conference Paper

References (5)

1. Iida H, Ito H, Nakazawa M et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J. Nucl. Med. 1995; 35: 2019-2030.
2. Sasaki, M. Effect of Zopiclone on sleep polysography in patients with insomnia. Proceedings of the Zopiclone Symposium Kinme, Rhone Poulene Japan, Tokyo, 1983.
3. Klimm HO, Dreyfus JF, Delmotte M. Zopiclone vs. Nitrazepam. A double blind comparative study of efficacy and tolerance in elderly patients with chronic insomnia. Sleep 1987; 10 (Suppl. 1): 73-78.
4. Pole P, Bonett EP, Schaffner R, Haefely W. A three-state model of the benzodiazepine receptor explains the interaction between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, b-carbolines and phenobarbital. Naunyn-Schmiedabergic Arch. Pharmacol. 1982; 321: 260-264.
5. Hirose N. Positive modulation by Aniracetam of the synaptic efficacy of the glutamatergic and cholinergic neurons. Jpn. Pharmacol. Therap. 1993; 21: 2361-2367.